Lymphoma stage 4 diffuse large B can be treated with a bone marrow transplant, but not every patient is cured.
Most hematologic malignant hematopoietic tumors are expected to be cured with a bone marrow transplant, but the cure rate is less than 100 percent. Even with a bone marrow transplant, there is a chance of recurrence.
Complications such as severe infections and severe graft-versus-host disease following bone marrow transplantation can be life-threatening.
In addition, the need for bone marrow transplantation for stage 4 diffuse large B-cell lymphoma should be further evaluated. Stage 4 lymphoma is only one of the prognostic factors, and the need for bone marrow transplantation should also be assessed in conjunction with the patient’s genetics and mid-term evaluation of the efficacy of the treatment, which is a costly option with serious complications.